Request Demo
Last update 08 May 2025
Recombinant human erythropoietin(Daying Pharmaceutical)
Last update 08 May 2025
Overview
Basic Info
Drug Type Colony-stimulating factors |
Synonyms 诺之素 |
Target |
Action agonists, stimulants |
Mechanism EPO receptor agonists(Erythropoietin receptor agonists), Erythropoiesis stimulants(Erythropoiesis stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (09 May 2002), |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with Recombinant human erythropoietin(Daying Pharmaceutical)ChiCTR2000032845
Prospective, open-label, multicenter clinical study on the efficacy and safety of recombinant human erythropoietin combined with retinoic acid and testosterone undecanoate in the treatment of anemia in patients with low-risk myelodysplastic syndrome
ChiCTR2000030594
Phase II / III clinical study on the efficacy and safety of recombinant human erythropoietin combined with retinoic acid and testosterone undecanoate in the treatment of anemia in patients with relatively low-risk myelodysplastic syndrome
IRCT2014122920471N1
Effects of Human Recombinant Erythropoietine on Functional Outcome of Traumatic Cervical Spine Cord Injury; A Randomized Placebo Controlled Study
100 Clinical Results associated with Recombinant human erythropoietin(Daying Pharmaceutical)
Login to view more data
100 Translational Medicine associated with Recombinant human erythropoietin(Daying Pharmaceutical)
Login to view more data
100 Patents (Medical) associated with Recombinant human erythropoietin(Daying Pharmaceutical)
Login to view more data
100 Deals associated with Recombinant human erythropoietin(Daying Pharmaceutical)
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Anemia | China | 09 May 2002 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Not Applicable | 245 | (Non users) | (drrrtkrntr) = pyvhjejsbq eatdtdogbd (yqxzzcwjzb ) | - | 01 Jun 2005 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free